Staged Double Hepatectomy, Double Total Vascular Exclusion, and Double Venous Reconstruction by Peritoneal Patches in On
- PDF / 190,007 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 25 Downloads / 199 Views
ORIGINAL ARTICLE – HEPATOBILIARY TUMORS
Staged Double Hepatectomy, Double Total Vascular Exclusion, and Double Venous Reconstruction by Peritoneal Patches in One Patient with Colorectal Liver Metastases Safi Dokmak, MD, Be´atrice Aussilhou, MD, Guillaume Levenson, MD, Giovanni Guarneri, MD, and Olivier Soubrane, MD Department of HPB Surgery and Liver Transplantation, Beaujon Hospital, Clichy, France
ABSTRACT Background. Surgical resection is the best treatment for colorectal liver metastases with good response to chemotherapy and in the absence of extrahepatic disease.1 With the amelioration of surgical technique, primary and recurrent colorectal liver metastases with venous invasion can be resected safely under short total vascular exclusion (TVE), and associated right thoracotomy can have a major benefit if resection at the hepato-caval junction is planned.2 The availability of the peritoneum as an autologous graft for venous reconstruction considerably facilitates the task of the surgeon.3 In this video, we present a patient who had staged double liver resection, double TVE, and double venous reconstruction by a peritoneal graft on the vena cava and the hepatic vein. Methods. In March 2017, a 47-year-old female was diagnosed with rectal cancer and synchronous liver metastases, microsatellite stability, and Kras mutation. The patient received folinic acid, fluorouracil, and oxaliplatin (FOLFOX) chemotherapy, with good response and a decrease in tumor markers. After chemotherapy, a computed tomography (CT) scan showed one lesion located on the right liver with lateral invasion of the vena cava, and
Electronic supplementary material The online version of this article (https://doi.org/10.1245/s10434-020-09155-5) contains supplementary material, which is available to authorized users. Ó Society of Surgical Oncology 2020 First Received: 8 May 2020 Accepted: 30 August 2020 S. Dokmak, MD e-mail: [email protected]
another lesion located in segment I. A liver-first strategy was decided and, in October 2017, the patient had a right hepatectomy extended to segment I and partially on the diaphragm, with lateral resection of the vena cava under isolated clampage of the vena cava and reconstruction with a peritoneal graft (60 mm). The patient received FOLFOX adjuvant chemotherapy for 3 months, and, while under radiotherapy for the rectal cancer, recurrence was diagnosed on the left liver lobe (two lesions), with lateral invasion of the left hepatic vein. Chemotherapy was shifted to folinic acid, fluorouracil, and irinotecan (FOLFIRI)– Avastin, with good response, allowing resection of the primary (T3N0M1), followed by adjuvant chemotherapy. In May 2019, the patient underwent two large resections on the left liver, including one under TVE, with opening of the diaphragm and intrathoracic control of the vena cava. The left hepatic vein was reconstructed laterally with a peritoneal graft (30 mm). Results. Postoperative outcome was uneventful and the two hospital stays were 12 and 15 days, respectively. For the first hepatect
Data Loading...
